Bethany Sensenig, a newly added director at Supernus, Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing no beneficial ownership of company securities as of the November 2, 2026 triggering event.
Key Highlights
- Reporting person: Bethany Sensenig, identified as a Director of Supernus, Inc. (NASDAQ:SUPN).
- Date of event: The event requiring the statement occurred on November 2, 2026.
- No securities held: According to the filing, "The Reporting Person does not beneficially own any securities of the Issuer as of the date of the event requiring this Statement."
- No derivative securities: Table II of the filing lists no derivative securities, including no options, warrants, or convertible securities.
- Signed by attorney-in-fact: The form was signed by Timothy C. Dec as attorney-in-fact on November 4, 2026, with a referenced Power of Attorney listed as Exhibit 24.
Sensenig's Initial Ownership Disclosure at Supernus, Inc.
Supernus, Inc. (NASDAQ:SUPN), a pharmaceutical company headquartered at 9715 Key West Avenue, Rockville, Maryland 20850, received an initial beneficial ownership statement from Bethany Sensenig following her addition as a Director. The event requiring the filing occurred on November 2, 2026, and the form was filed two days later, on November 4, 2026.
As reported in the filing, Sensenig holds no direct or indirect beneficial ownership of Supernus common stock or any derivative securities as of the event date. Both Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, are blank. The filing states explicitly: "No securities are beneficially owned."
The form was submitted by One Reporting Person, as indicated in the filing, and was executed by Timothy C. Dec acting as attorney-in-fact pursuant to a Power of Attorney filed as Exhibit 24. No amendments to a prior Form 3 are indicated, as this is an initial statement.
What Was Disclosed
Bethany Sensenig filed a Form 3 as a newly appointed Director of Supernus, Inc., disclosing zero beneficial ownership of any company securities, both direct and indirect, in both common stock and derivative categories, as of November 2, 2026.



Please wait processing your request...